Valuation: GI Innovation, Inc.

Market Cap 57TCr 40Cr 35Cr 32Cr 30Cr 56Cr 3.81TCr 56Cr 381.28Cr 149.04Cr 1.91TCr 149.94Cr 146.68Cr 6.36TCr P/E 2024
-6.04x
P/E 2025 -29.2x
Enterprise Value 53TCr 37Cr 32Cr 30Cr 28Cr 52Cr 3.58TCr 53Cr 357.94Cr 139.92Cr 1.79TCr 140.76Cr 137.7Cr 5.97TCr EV / Sales 2024
15,970x
EV / Sales 2025 187x
Free-Float
93.28%
Yield 2024 *
-
Yield 2025 -
1 day-5.90%
1 week+2.57%
Current month+18.35%
1 month+6.95%
3 months-37.93%
6 months-38.93%
Current year-50.28%
1 week 7,870
Extreme 7870
9,650
1 month 6,470
Extreme 6470
9,650
Current year 6,470
Extreme 6470
18,830
1 year 6,470
Extreme 6470
21,000
3 years 6,470
Extreme 6470
24,900
5 years 6,470
Extreme 6470
24,900
10 years 6,470
Extreme 6470
24,900
Manager TitleAgeSince
Chief Executive Officer 58 02/07/2025
Chief Executive Officer 54 16/06/2021
Director of Finance/CFO - 01/09/2024
Director TitleAgeSince
Director/Board Member 44 -
Director/Board Member 55 -
Director/Board Member 51 03/03/2022
Date Insider Type Main position Quantity % Market Cap.
20/01/26 Expiration 14 0.0000%
20/01/26 Fiscal year

Chief Technology Officer

445 0.0007%
20/01/26 Fiscal year 14 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-5.90%+2.57%-52.29%-34.49% 43Cr
-1.60%+1.76%+4.62%+14.41% 4.95TCr
-0.14%+4.03%+482.13%+584.20% 4.41TCr
-0.06%+9.62%+24.63%+75.89% 4.08TCr
-0.87%+2.40%+30.01%+9.81% 4.01TCr
-4.04%+8.72%+22.60%+48.00% 3.42TCr
-1.41%+1.57%+29.98%+124.75% 1.69TCr
+0.35%+4.61% - - 1.68TCr
-0.43%+1.13%+5.04%+20.83% 1.4TCr
+0.84%+9.07%+86.17%+31.11% 1.35TCr
Average -1.33%+6.55%+70.32%+97.17% 2.7TCr
Weighted average by Cap. -1.04%+6.50%+103.21%+135.64%

Financials

2024 2025
Net sales 2.43Cr 17.14T 14.85T 13.91T 12.69T 23.86T 16.35L 24.22T 2L 63.96T 8L 64.35T 62.95T 27.29L 583.81Cr 41.2L 35.7L 33.45L 30.51L 57.36L 39Cr 58.24L 3.93Cr 1.54Cr 20Cr 1.55Cr 1.51Cr 66Cr
Net income -5.88TCr -4.15Cr -3.59Cr -3.37Cr -3.07Cr -5.78Cr -395.73Cr -5.86Cr -40Cr -15Cr -198.15Cr -16Cr -15Cr -660.71Cr -3.51TCr -2.48Cr -2.15Cr -2.01Cr -1.84Cr -3.45Cr -236.52Cr -3.5Cr -24Cr -9.25Cr -118.43Cr -9.31Cr -9.11Cr -394.9Cr
Net Debt -343.96Cr -24.28L -21.03L -19.71L -17.97L -33.79L -23Cr -34.31L -2.32Cr -90.6L -12Cr -91.15L -89.17L -39Cr -3.46TCr -2.44Cr -2.12Cr -1.98Cr -1.81Cr -3.4Cr -233.1Cr -3.45Cr -23Cr -9.12Cr -116.72Cr -9.18Cr -8.98Cr -389.19Cr
Logo GI Innovation, Inc.
GI Innovation Inc is a Korea-based company engaged in the research and development of next-generation immunotherapies based on fusion proteins. The Company is engaged in the business of generating revenue through license fees by technology transfer of new drug candidates in pre-clinical and early clinical stages. The core new drug pipeline includes products such as GI-101 immuno-oncology and GI-301 allergy treatment.
Employees
-
Date Price Change Volume
12/26/12 8,770.00 -5.90% 5,45,895
11/26/11 ₩9,320.00 +0.87% 2,88,292
10/26/10 ₩9,240.00 +8.07% 4,32,800
07/26/07 ₩8,550.00 +0.23% 2,73,452
06/26/06 ₩8,530.00 +4.15% 4,33,692
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC
  1. Stock Market
  2. Stocks
  3. A358570 Stock